By Mauro Orru
BASF SE said Monday that it has agreed with Sandoz GmbH, a subsidiary of Swiss pharmaceutical major Novartis AG, to make investments at the company's Kundl/Schaftenau Campus in Austria.
The German chemicals company didn't disclose financial details for the agreement signed on April 26, which is aimed at bolstering BASF's production footprint for enzymes and biotechnology products.
The start of production is planned for 2024, BASF said.
Write to Mauro Orru at email@example.com; @MauroOrru94
(END) Dow Jones Newswires